A third generation glutamate sensor with a fluorescent readout offers insights into neuronal communication.
View Full Profile
Learn about our Editorial Policies.
The third generation of glutamate sensors, iGluSnFR3, tracks glutamate release at the synapse level.1 Upon binding to glutamate, the reporter changes its conformation, intensifying the signal of its fluorescent protein.
Read the full story.
Mariella joined The Scientist in 2023. Before that, she was a postdoctoral researcher at the Uniformed Services University of the Health Sciences studying sex differences on the effects of chronic stress and traumatic brain injury. Mariella holds a master’s and a PhD in neuroscience from the Universidade Federal de Sao Paulo, Brazil, and a certificate in Science Communication from the University of California, San Diego.
View Full Profile
To understand how memories are formed and maintained, neuroscientists travel far beyond the cell body in search of answers.
Memory-enhancing neural networks may also drive involuntary musical loops in the brain.
View this Issue
In this webinar, Brian Hie will discuss Evo2, a state-of-the-art genomic foundation model capable of generalist prediction and design tasks across DNA, RNA, and proteins.
In this webinar, learn how scientists use advanced human brain models to uncover treatment strategies for complex neurological conditions.
Manufacturing cell-based therapeutics requires a robust workflow from start to finish.
Modern DNA synthesis platforms empower researchers to explore the molecular world, from next-generation sequencing to cell and gene therapy development.
This new product line is specifically engineered to meet the rigorous demands of immunology research, vaccine development, animal studies, cell and gene therapy, and therapeutic protein manufacturing.
New fluidics and clog detection systems further simplify operation and reduce instrument downtime
Researchers aim to discover dominant subtypes of plasmablasts initiating from the MMR vaccine in order to develop neutralizing antibody candidate therapies
Study identifies new metrics to enhance scRNA-seq based virtual cell modelling
